Growing Regulatory Expertise Arriello’s expanding leadership team with senior professionals in Project Management, Quality & Compliance, and Drug Safety indicates a strong focus on enhancing its regulatory and pharmacovigilance capabilities, presenting opportunities to offer advanced compliance and safety solutions.

European Expansion With headquarters in Ireland and active operations across Europe, Arriello’s regional presence offers potential for localized technology, consultancy, and regulatory service upgrades tailored to European pharmaceutical and biotech companies.

Diversified Service Portfolio Providing end-to-end services from clinical to post-submission regulatory affairs and pharmacovigilance, Arriello is well-positioned to adopt innovative software tools and compliance solutions to optimize its integrated service offerings.

Mid-market Focus With a revenue range of 1 to 10 million and a workforce of up to 200 employees, Arriello targets mid-sized life sciences firms, creating opportunities to introduce scalable, cost-effective regulatory and safety technology solutions.

Industry Recognition Participation as a platinum sponsor at the World Drug Safety Congress Americas highlights Arriello’s industry reputation, paving the way for partnerships, vendor collaborations, and technology integrations in global pharmacovigilance initiatives.